Pharmacology of argatroban

Expert Opinion on Investigational Drugs

Volumn 8, Issue 5, 1999, Pages 625-654

  Jeske, W ^a   Walenga, J M ^a   Lewis, B E ^a   Fareed, J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antithrombotic; Argatroban; Thrombin inhibitor

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN; ARGATROBAN; HEPARIN; THROMBIN; THROMBIN INHIBITOR; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTERY THROMBOSIS; BRAIN ISCHEMIA; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG METABOLISM; DRUG MONITORING; DRUG POTENTIATION; DRUG SPECIFICITY; EXTRACORPOREAL CIRCULATION; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; META ANALYSIS; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PLASMAPHERESIS; REVIEW; STROKE; THROMBOCYTOPENIA; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY; VEIN THROMBOSIS;

EID: 0032958062     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.8.5.625     Document Type: Review

References (142)